Lithuania vs Qatar: The number of people with susceptibility test result for rifampicin
Lithuania
465
in 2021
Qatar
411
in 2021
Lithuania rank
82nd
Qatar rank
84th
The number of people with susceptibility test result for rifampicin over time
- Lithuania
- Qatar
How they compare
Lithuania currently reports 465 against 411 in Qatar, a difference of 54.
That makes Lithuania's figure about 1.1 times Qatar's.
Across all 5 years both countries report, Lithuania has been ahead every year.
Lithuania ranks 82nd and Qatar ranks 84th of 155 countries.
Lithuania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lithuania | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 777 | 297.67 | 479.33 | Lithuania |
| 2020s | 474 | 392.5 | 81.5 | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Lithuania or Qatar?
- Lithuania, at 465 against 411 in Qatar as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Lithuania and Qatar?
- 54, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and Qatar?
- 5 years are reported by both, from 2017 to 2021.
- How do Lithuania and Qatar rank globally for the number of people with susceptibility test result for rifampicin?
- Lithuania ranks 82nd and Qatar ranks 84th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.